GSK to expand hepatology pipeline with potential best-in-class therapy
The unique mechanism of action of efimosfermin supports its potential as a new standard-of-care in liver disease.
List view / Grid view
The unique mechanism of action of efimosfermin supports its potential as a new standard-of-care in liver disease.
A Fortune report reveals the best 10 places to work in the US biopharmaceutical industry.